Internal Medicine, Medical Oncology · New York, NY
NPI
1770648875
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Ave
New York, NY, 10021
Phone (646) 227-3275
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
685 services
Medicare patients, 2024
188
Average age 73
Drug cost, 2024
$2.9M
844 prescriptions
Company payments, 2025
$5,513
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory J Riely was code 99214 (office e&m - established), 580 times for 143 patients. In total Gregory J Riely billed 685 services in 12 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 580 | 143 | $87.56 | $51K |
| 99205 Office E&M - New | Office | 35 | 35 | $154.05 | $5,392 |
| 99215 Office E&M - Established | Office | 25 | 23 | $127.14 | $3,179 |
| 99233 Hospital E&M - Subsequent | Facility | 24 | 13 | $102.44 | $2,458 |
By year: 2022 $51K for 539 services; 2023 $66K for 706 services; 2024 $63K for 685 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gregory J Riely prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 98 prescriptions and refills. In total Gregory J Riely wrote 844 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 98 | 98 | 11 | $1.6M |
| Prednisone Generic | 61 | 69 | 15 | $242 |
| Alprazolam Generic | 38 | 38 | Under 11 | $172 |
| Dexamethasone Generic | 37 | 37 | 22 | $548 |
| Pantoprazole Sodium Generic | 35 | 41 | 12 | $144 |
| Ondansetron Hcl Generic | 34 | 34 | 22 | $148 |
| Levothyroxine Sodium Generic | 30 | 64 | Under 11 | $229 |
| Eliquis Apixaban | 26 | 32 | Under 11 | $18K |
| Xarelto Rivaroxaban | 24 | 30 | Under 11 | $17K |
| Oxycodone Hcl Generic | 23 | 23 | Under 11 | $206 |
| Alecensa Alectinib Hcl | 22 | 22 | Under 11 | $247K |
| Everolimus Generic | 20 | 20 | Under 11 | $123K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 17 | 20 | Under 11 | $697 |
| Lumakras Sotorasib | 15 | 15 | Under 11 | $228K |
| Xalkori Crizotinib | 14 | 14 | Under 11 | $278K |
Brand drugs: - claims; generic drugs: 550 claims; opioid claims: 39.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gregory J Riely $5,513 ($233 in general payments such as food, travel and fees and $5,280 for research) from 6 companies. The largest payer was Pfizer Inc. with $4,360.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.